Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Gynecologic cancer treatment: risk factors for therapeutically induced neoplasia

Conference · · Cancer, Suppl.; (United States)
OSTI ID:6120482
Therapeutic intervention in a course of illness, while producing the desired result, also may have some adverse long-term effects on the patient. Second malignancies are one of the known complications of therapy. The treatments of gynecologic cancers by surgery, irradiation and chemotherapy have been associated with subsequent neoplasms. The use of normal skin from the thigh to fabricate an artificial vagina has resulted in more squamous cell carcinomas than expected. Alkylating agents used in the treatment of ovarian cancer and other diseases have been shown to lead to an increased risk of leukemia. The incidence of lymphoma and uterine, urinary bladder and colon carcinomas has been associated with prior irradiation for gynecologic disease. The literature regarding the therapeutically induced risk factors in gynecologic therapy is reviewed and areas of our knowledge that require more investigation are identified.
Research Organization:
National Cancer Inst., Bethesda, MD
OSTI ID:
6120482
Conference Information:
Journal Name: Cancer, Suppl.; (United States) Journal Volume: 48:2
Country of Publication:
United States
Language:
English

Similar Records

Gynecologic cancer treatment: risk factors for therapeutically induced neoplasia
Journal Article · Wed Jul 15 00:00:00 EDT 1981 · Cancer (Philadelphia); (United States) · OSTI ID:5365820

Carcinoma of vagina 10 or more years following pelvic irradiation therapy
Journal Article · Mon Feb 28 23:00:00 EST 1977 · Am. J. Obstet. Gynecol.; (United States) · OSTI ID:7120492

Treatment-related cancers after gynecologic malignancy
Journal Article · Thu Oct 15 00:00:00 EDT 1987 · Cancer (Philadelphia); (United States) · OSTI ID:5716441